Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Summit Therapeutics Initiates Global Phase III HARMONi-GI3 Trial Evaluating Ivonescimab Plus Chemotherapy In Metastatic Colorectal Cancer

Author: Benzinga Newsdesk | October 17, 2025 06:04am

HARMONi-GI3 is the Fourth Global Phase III Study of Ivonescimab and First Global Study beyond NSCLC
Clinical Trial Site Activations Planned to Begin This Quarter in the United States
Conference Call to be Held at 8:00am ET on Monday, October 20, 2025

Posted In: SMMT